{"id":3488,"date":"2020-12-14T08:29:22","date_gmt":"2020-12-14T08:29:22","guid":{"rendered":"http:\/\/dev.sunpharma.com\/?page_id=3488"},"modified":"2025-07-29T09:50:33","modified_gmt":"2025-07-29T04:20:33","slug":"credit-rating","status":"publish","type":"page","link":"https:\/\/dev.sunpharma.com\/he\/investors\/credit-rating\/","title":{"rendered":"Investors &#8211; Credit-Rating"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; admin_label=&#8221;Popup &#8211; #undefined&#8221; _builder_version=&#8221;4.7.4&#8243; background_image=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/03\/investor-banner.jpg&#8221; parallax=&#8221;on&#8221; da_disable_devices=&#8221;off|off|off&#8221; saved_tabs=&#8221;all&#8221; collapsed=&#8221;off&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_fullwidth_header title=&#8221;Investor Information&#8221; header_fullscreen=&#8221;on&#8221; button_one_url=&#8221;#visionvalues&#8221; button_two_url=&#8221;#codeofconduct&#8221; _builder_version=&#8221;4.7.4&#8243; title_font=&#8221;|700|||||||&#8221; title_text_color=&#8221;#f7941e&#8221; title_font_size=&#8221;40px&#8221; title_line_height=&#8221;1.2em&#8221; content_font=&#8221;||||||||&#8221; content_text_color=&#8221;#000000&#8243; content_line_height=&#8221;1.8em&#8221; subhead_font=&#8221;||||||||&#8221; subhead_text_color=&#8221;rgba(0,0,0,0.6)&#8221; subhead_font_size=&#8221;22px&#8221; subhead_line_height=&#8221;1.4em&#8221; background_color=&#8221;rgba(255,255,255,0.7)&#8221; custom_button_one=&#8221;on&#8221; button_one_text_size=&#8221;20px&#8221; button_one_text_color=&#8221;#ffffff&#8221; button_one_bg_color=&#8221;#f7941e&#8221; button_one_border_width=&#8221;0px&#8221; button_one_font=&#8221;|||on|||||&#8221; button_one_use_icon=&#8221;off&#8221; custom_button_two=&#8221;on&#8221; button_two_text_size=&#8221;20px&#8221; button_two_text_color=&#8221;rgba(0,0,0,0.7)&#8221; button_two_bg_color=&#8221;#ffffff&#8221; button_two_border_width=&#8221;0px&#8221; button_two_font=&#8221;|||on|||||&#8221; button_two_use_icon=&#8221;off&#8221; button_two_custom_margin=&#8221;||||false|false&#8221; button_two_custom_margin_tablet=&#8221;&#8221; button_two_custom_margin_phone=&#8221;|||1px|false|false&#8221; button_two_custom_margin_last_edited=&#8221;on|desktop&#8221; button_two_custom_padding=&#8221;||||false|false&#8221; background_layout=&#8221;light&#8221; width=&#8221;50%&#8221; width_tablet=&#8221;&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|phone&#8221; animation_style=&#8221;fade&#8221; animation_duration=&#8221;500ms&#8221; animation_delay=&#8221;300ms&#8221; title_font_tablet=&#8221;&#8221; title_font_phone=&#8221;&#8221; title_font_last_edited=&#8221;on|phone&#8221; content_font_tablet=&#8221;&#8221; content_font_phone=&#8221;&#8221; content_font_last_edited=&#8221;on|phone&#8221;]At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Popup &#8211; #undefined&#8221; _builder_version=&#8221;4.7.4&#8243; background_color=&#8221;rgba(0,0,0,0)&#8221; da_disable_devices=&#8221;off|off|off&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.7.4&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||true|false&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||26px|||&#8221;]<\/p>\n<h2 style=\"font-weight: bold; font-size: 25px; color: #f7941e!important; line-height: 1.2em;\">Credit Rating<\/h2>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; hover_enabled=&#8221;0&#8243; sticky_enabled=&#8221;0&#8243; module_id=&#8221;credit-table&#8221;]<\/p>\n<table width=\"100%\" style=\"font-weight: 400; border-color: #000;\">\n<tbody>\n<tr>\n<td width=\"28%\"><strong>Rating Agency<\/strong><\/td>\n<td width=\"44%\"><strong>Instrument Type<\/strong><\/td>\n<td width=\"26%\"><strong>Rating<\/strong><\/td>\n<\/tr>\n<tr>\n<td rowspan=\"2\" width=\"28%\">ICRA Limited<\/td>\n<td width=\"44%\">Long-Term\/Short-Term , Fund-based\/Non-fund Based Limits<\/td>\n<td width=\"26%\">AAA (Stable)\/ A1+<\/td>\n<\/tr>\n<tr>\n<td width=\"44%\">Commercial Paper<\/td>\n<td width=\"26%\">A1+<\/td>\n<\/tr>\n<tr>\n<td rowspan=\"3\" width=\"28%\">CRISIL Limited<\/td>\n<td width=\"44%\">Bank Facility (Short-Term)<\/td>\n<td width=\"26%\">A1+<\/td>\n<\/tr>\n<tr>\n<td width=\"44%\">Bank Facility (Long-Term)<\/td>\n<td width=\"26%\">AAA\/ Stable<\/td>\n<\/tr>\n<tr>\n<td width=\"44%\">Commercial Paper<\/td>\n<td width=\"26%\">A1+<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.Credit Rating Rating Agency Instrument Type Rating ICRA Limited Long-Term\/Short-Term , Fund-based\/Non-fund Based Limits AAA (Stable)\/ A1+ Commercial Paper A1+ CRISIL Limited Bank Facility (Short-Term) A1+ Bank [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":37,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-3488","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholder\u2019s Information | Credit Rating - Sun Pharmaceutical<\/title>\n<meta name=\"description\" content=\"CRISIL Ltd. has assigned the highest credit rating of \u2018CRISIL A1+ and CRISIL AAA\/Stable\u2019 for short term &amp; long term bank facilities and commercial paper programs of the Company.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dev.sunpharma.com\/he\/investors\/credit-rating\/\" \/>\n<meta property=\"og:locale\" content=\"he_IL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholder\u2019s Information | Credit Rating - Sun Pharmaceutical\" \/>\n<meta property=\"og:description\" content=\"CRISIL Ltd. has assigned the highest credit rating of \u2018CRISIL A1+ and CRISIL AAA\/Stable\u2019 for short term &amp; long term bank facilities and commercial paper programs of the Company.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.sunpharma.com\/he\/investors\/credit-rating\/\" \/>\n<meta property=\"og:site_name\" content=\"Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-29T04:20:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u05d3\u05e7\u05d41\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/credit-rating\\\/\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/credit-rating\\\/\",\"name\":\"Shareholder\u2019s Information | Credit Rating - Sun Pharmaceutical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\"},\"datePublished\":\"2020-12-14T08:29:22+00:00\",\"dateModified\":\"2025-07-29T04:20:33+00:00\",\"description\":\"CRISIL Ltd. has assigned the highest credit rating of \u2018CRISIL A1+ and CRISIL AAA\\\/Stable\u2019 for short term & long term bank facilities and commercial paper programs of the Company.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/credit-rating\\\/#breadcrumb\"},\"inLanguage\":\"he-IL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/credit-rating\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/credit-rating\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.sunpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investors\",\"item\":\"https:\\\/\\\/dev.sunpharma.com\\\/investors\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Investors &#8211; Credit-Rating\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/\",\"name\":\"Sun Pharmaceutical Industries Ltd.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.sunpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"he-IL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholder\u2019s Information | Credit Rating - Sun Pharmaceutical","description":"CRISIL Ltd. has assigned the highest credit rating of \u2018CRISIL A1+ and CRISIL AAA\/Stable\u2019 for short term & long term bank facilities and commercial paper programs of the Company.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dev.sunpharma.com\/he\/investors\/credit-rating\/","og_locale":"he_IL","og_type":"article","og_title":"Shareholder\u2019s Information | Credit Rating - Sun Pharmaceutical","og_description":"CRISIL Ltd. has assigned the highest credit rating of \u2018CRISIL A1+ and CRISIL AAA\/Stable\u2019 for short term & long term bank facilities and commercial paper programs of the Company.","og_url":"https:\/\/dev.sunpharma.com\/he\/investors\/credit-rating\/","og_site_name":"Sun Pharmaceutical Industries Ltd.","article_modified_time":"2025-07-29T04:20:33+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"\u05d3\u05e7\u05d41"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.sunpharma.com\/investors\/credit-rating\/","url":"https:\/\/dev.sunpharma.com\/investors\/credit-rating\/","name":"Shareholder\u2019s Information | Credit Rating - Sun Pharmaceutical","isPartOf":{"@id":"https:\/\/dev.sunpharma.com\/#website"},"datePublished":"2020-12-14T08:29:22+00:00","dateModified":"2025-07-29T04:20:33+00:00","description":"CRISIL Ltd. has assigned the highest credit rating of \u2018CRISIL A1+ and CRISIL AAA\/Stable\u2019 for short term & long term bank facilities and commercial paper programs of the Company.","breadcrumb":{"@id":"https:\/\/dev.sunpharma.com\/investors\/credit-rating\/#breadcrumb"},"inLanguage":"he-IL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.sunpharma.com\/investors\/credit-rating\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.sunpharma.com\/investors\/credit-rating\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.sunpharma.com\/"},{"@type":"ListItem","position":2,"name":"Investors","item":"https:\/\/dev.sunpharma.com\/investors\/"},{"@type":"ListItem","position":3,"name":"Investors &#8211; Credit-Rating"}]},{"@type":"WebSite","@id":"https:\/\/dev.sunpharma.com\/#website","url":"https:\/\/dev.sunpharma.com\/","name":"Sun Pharmaceutical Industries Ltd.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.sunpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"he-IL"}]}},"_links":{"self":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/3488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/comments?post=3488"}],"version-history":[{"count":14,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/3488\/revisions"}],"predecessor-version":[{"id":17704,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/3488\/revisions\/17704"}],"up":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/37"}],"wp:attachment":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/media?parent=3488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}